| abstract |
The present invention relates to first active ingredients and phosphodiesterase inhibitors that are selected muscarinic receptor antagonists, modulators of chemokine receptor function, inhibitors of kinase function, protease inhibitors, steroidal glucocorticoid receptor agonists, non-steroidal A medicament, kit or composition for use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease and asthma, comprising a second active ingredient selected from glucocorticoid receptor agonists and purine receptor antagonists provide. |